Neumora Therapeutics (NMRA) Sales of Property, Plant and Equipment (2025 - 2026)

Neumora Therapeutics (NMRA) Sales of Property, Plant and Equipment (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27,000.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Neumora Therapeutics 303.08 Mn 303.08 Mn - 71,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 71,000.00
Mar 31, 2026 71,000.00
Dec 31, 2025 47,000.00
Dec 31, 2025 47,000.00
Sep 30, 2025 87,000.00
Sep 30, 2025 87,000.00
Jun 30, 2025 84,000.00
Jun 30, 2025 84,000.00